The UK on Thursday approved two drugs to be used in treating patients with COVID-19, a disease caused by the CCP (Chinese Communist Party) virus, commonly known as novel coronavirus.
The two new drugs, tocilizumab and sarilumab, typically used to treat rheumatoid arthritis, are monoclonal antibodies that target a protein called interleukin-6, which is thought to be important in the COVID-19 infection pathway.
